A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)

Sitagliptin (MK0431) Phase III Double-blind Comparative Study - Type 2 Diabetes Mellitus -

NCT00411554•Merck Sharp & Dohme LLC

Summary

The clinical study determines the safety and efficacy of Sitagliptin (MK0431) in patients with type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy.

Eligibility

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients have type 2 diabetes mellitus on diet/exercise therapy

Exclusion Criteria

•Patients have type 1 diabetes mellitus

Key Dates

Start Date

January 1, 2007

Primary Completion Date

August 1, 2007

Completion Date

August 1, 2007

Last Updated

February 5, 2016

Enrollment

319

ACTUAL participants

Conditions

Diabetes Mellitus, Non-Insulin-Dependent

Interventions

sitagliptin phosphate

DRUG

Comparator: voglibose

DRUG

Technology Intensified Diabetes Education Study in African Americans

NCT02088658

Diabetes Mellitus, Type 2Diabetes Mellitus, Adult-Onset+3 more

View study

COMPLETEDPHASE1

PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA

NCT02113163

Diabetes Mellitus, Non-Insulin-DependentHypertriglyceridemia

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 5, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)

Inclusion Criteria

Exclusion Criteria

Technology Intensified Diabetes Education Study in African Americans

PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA

Diabetes Prevention Program

Effect of Gelofusine on GLP1-receptor Imaging

Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea